Abvc Biopharma Inc Expected To Post A Loss Of 12 Cents A Share: Earnings Preview

ABVC Biopharma

11/11/2022 11:34

* ABVC Biopharma Inc  ABVC.OQ   ABVC.O  is expected to show
a fall
in quarterly revenue when it reports  results on November 14
(estimated). 
    * The Fremont California-based  company is expected to
report  a
86.9% decrease in revenue to $13 thousand from $99 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ABVC Biopharma Inc
is for
a loss of 12 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ABVC
Biopharma
Inc is $3​, above​ its last closing price of $0.76. ​​​

This summary was machine generated November 11 at 11:33 GMT. 
All figures in US dollars  unless otherwise stated